Migraine: open trials in France

14 open trials have a site in France. Registry data; only the trial team decides who can take part.

NCT07877493
Psychological Support for Chronic Migraine Patients Treated With Anti-CGRP (Anti-Calcitonin Gene-Related Peptide ) Monoclonal Antibodies
Research · Central Hospital, Nancy, France
CHRU, Nancy
Registry updated 2026-10-16
NCT05156398
Efficacy and Safety Study of Rimegepant for the Preventative Treatment of Migraine in Pediatric Subjects
Trial Treatment · Phase 3 · Pfizer
Centre Hospitalier Intercommunal Créteil, Créteil · Centre Hospitalier Universitaire De Montpellier, Montpellier Cedex 5 · Hopital Des Enfants, Toulouse Cedex 9
Registry updated 2026-10-14
NCT07067112
Suppressive Functions of Regulatory T Cells in Migraine
Trial Treatment · University Hospital, Clermont-Ferrand
CHU Clermont-Ferrand, Clermont-Ferrand
Registry updated 2026-10-14
NCT05711394
A Study to Assess the Adverse Events and Change in Disease Activity of Oral Atogepant Tablets in Pediatric Participants (6-17 Years of Age) With Episodic Migraine
Trial Treatment · Phase 3 · AbbVie
Centre Hospitalier Universitaire Amiens - Picardie, Amiens · Centre Hospitalier Intercommunal Créteil, Créteil · Centre Hospitalier Universitaire de Toulouse, Toulouse
Registry updated 2026-10-06
NCT07691164
Evolution of the Cognitive Profile and Quality of Life of Adult Patients Suffering From Severe Migraines Under Preventive Treatment
Trial Treatment · University Hospital, Strasbourg, France
Hopitaux Universitaires de Strasbourg, Strasbourg
Registry updated 2026-07-08
NCT07598045
Efficacy of Anti-IL-6 Treatments on Migraine in Patients Treated With Anti-IL-6 for a Rheumatological Condition
Research · University Hospital, Clermont-Ferrand
CHU Clermont-Ferrand, Clermont-Ferrand
Registry updated 2026-06-04
NCT07177885
Tryptophan as a Modulating Factor in the Antimigraine Efficacy of Triptans
Research · University Hospital, Clermont-Ferrand
CHU de Clermont-Ferrand, Clermont-Ferrand
Registry updated 2026-03-09
NCT04063540
Acid-Sensing Ion Channel and Migraine Disease Proof of Concept Study on the Efficacy of Amiloride in the Prophylaxis of Migraine Aura
Trial Treatment · Phase 2 · Centre Hospitalier Universitaire de Nice
Hôpital Pierre Wertheimer, Bron · Chu Gabriel Montpied, Clermont-Ferrand · AP-HM, Marly · CHU de Montpellier, Montpellier · CHU de Nice, Nice
Registry updated 2025-12-04
NCT06426316
The Role of Cytokines and Regulatory T Lymphocytes in Migraine Pathophysiology.
Trial Treatment · University Hospital, Clermont-Ferrand
CHU de Clermont-Ferrand - Service de Neurologie, Clermont-Ferrand
Registry updated 2025-11-20
NCT05707949
Long-term Extension Study to Assess Adverse Events of Oral Atogepant Tablets in Pediatric Participants (6 to 17 Years of Age) With Migraine
Trial Treatment · Phase 3 · AbbVie
Centre Hospitalier Universitaire Amiens - Picardie, Amiens · Centre Hospitalier Intercommunal Créteil, Créteil · Centre Hospitalier Universitaire de Toulouse, Toulouse
Registry updated 2025-08-11
NCT07081685
Efficacy of Non-Invasive Neuromodulation on Pain in Migraine
Trial Treatment · University Hospital, Clermont-Ferrand
CHU Clermont-Ferrand, Clermont-Ferrand
Registry updated 2025-07-23
NCT06623188
Treatment of Episodic Migraine With AURICular Neuromodulation
Trial Treatment · Hôpital Européen Marseille
BENNANI, Marseille · Hopital Europeen Marseille, Marseille
Registry updated 2025-07-01
NCT06224959
Migraine and Neuropathic Pain in Osteoarthritis
Research · University Hospital, Clermont-Ferrand
CHU Clermont-Ferrand, Clermont-Ferrand
Registry updated 2025-03-10
NCT04925414
Migraine and High Flow Oxygenotherapy at the Emergency Department (MiOx)
Trial Treatment · Phase 4 · Centre Hospitalier Universitaire de Nice
CHU de Nice, Nice
Registry updated 2024-11-18

All Migraine trials and the map

This page is not medical advice. Talk to your doctor before contacting a trial.

Report an error